Literature DB >> 33327970

Comorbidity and severity-of-illness risk adjustment for hospital-onset Clostridioides difficile infection using data from the electronic medical record.

Stephanie M Cabral1, Katherine E Goodman1, Natalia Blanco1, Surbhi Leekha1, Larry S Magder1, Gita Nadimpalli1, Lisa Pineles1, Kerri A Thom1, Anthony D Harris1.   

Abstract

OBJECTIVE: To determine whether electronically available comorbidities and laboratory values on admission are risk factors for hospital-onset Clostridioides difficile infection (HO-CDI) across multiple institutions and whether they could be used to improve risk adjustment. PATIENTS: All patients at least 18 years of age admitted to 3 hospitals in Maryland between January 1, 2016, and January 1, 2018.
METHODS: Comorbid conditions were assigned using the Elixhauser comorbidity index. Multivariable log-binomial regression was conducted for each hospital using significant covariates (P < .10) in a bivariate analysis. Standardized infection ratios (SIRs) were computed using current Centers for Disease Control and Prevention (CDC) risk adjustment methodology and with the addition of Elixhauser score and individual comorbidities.
RESULTS: At hospital 1, 314 of 48,057 patient admissions (0.65%) had a HO-CDI; 41 of 8,791 patient admissions (0.47%) at community hospital 2 had a HO-CDI; and 75 of 29,211 patient admissions (0.26%) at community hospital 3 had a HO-CDI. In multivariable regression, Elixhauser score was a significant risk factor for HO-CDI at all hospitals when controlling for age, antibiotic use, and antacid use. Abnormal leukocyte level at hospital admission was a significant risk factor at hospital 1 and hospital 2. When Elixhauser score was included in the risk adjustment model, it was statistically significant (P < .01). Compared with the current CDC SIR methodology, the SIR of hospital 1 decreased by 2%, whereas the SIRs of hospitals 2 and 3 increased by 2% and 6%, respectively, but the rankings did not change.
CONCLUSIONS: Electronically available patient comorbidities are important risk factors for HO-CDI and may improve risk-adjustment methodology.

Entities:  

Mesh:

Year:  2020        PMID: 33327970      PMCID: PMC8507318          DOI: 10.1017/ice.2020.1344

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   6.520


  24 in total

1.  Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.

Authors:  Michael D Howell; Victor Novack; Philip Grgurich; Diane Soulliard; Lena Novack; Michael Pencina; Daniel Talmor
Journal:  Arch Intern Med       Date:  2010-05-10

2.  Incidence of Clostridium difficile infection in inflammatory bowel disease.

Authors:  Joseph F Rodemann; Erik R Dubberke; Kimberly A Reske; Da Hea Seo; Christian D Stone
Journal:  Clin Gastroenterol Hepatol       Date:  2007-03       Impact factor: 11.382

3.  A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data.

Authors:  Carl van Walraven; Peter C Austin; Alison Jennings; Hude Quan; Alan J Forster
Journal:  Med Care       Date:  2009-06       Impact factor: 2.983

4.  Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database.

Authors:  Hude Quan; Bing Li; L Duncan Saunders; Gerry A Parsons; Carolyn I Nilsson; Arif Alibhai; William A Ghali
Journal:  Health Serv Res       Date:  2008-08       Impact factor: 3.402

5.  Validity of ascertainment of co-morbid illness using administrative databases: a systematic review.

Authors:  J R Leal; K B Laupland
Journal:  Clin Microbiol Infect       Date:  2009-07-15       Impact factor: 8.067

6.  Burden of Clostridium difficile infection in the United States.

Authors:  Martijn Bouwknegt; Sofie van Dorp; Ed Kuijper
Journal:  N Engl J Med       Date:  2015-06-11       Impact factor: 91.245

7.  Factors associated with Clostridium difficile infection: A nested case-control study in a three year prospective cohort.

Authors:  Nagham Khanafer; Philippe Vanhems; Frédéric Barbut; Christine Luxemburger; Clarisse Demont; Monique Hulin; Olivier Dauwalder; François Vandenesch; Laurent Argaud; Lionel Badet; Xavier Barth; Malik Bertrand; Carole Burillon; Roland Chapurlat; Michel Chuzeville; Brigitte Comte; François Disant; Michel Henry Fessy; Christian Gouillat; Laurent Juillard; Patrick Lermusiaux; Olivier Monneuse; Emmanuel Morelon; Jacques Ninet; Thierry Ponchon; Emmanuel Poulet; Thomas Rimmele; Karim Tazarourte
Journal:  Anaerobe       Date:  2017-03-06       Impact factor: 3.331

8.  Predicting the risk for hospital-onset Clostridium difficile infection (HO-CDI) at the time of inpatient admission: HO-CDI risk score.

Authors:  Ying P Tabak; Richard S Johannes; Xiaowu Sun; Carlos M Nunez; L Clifford McDonald
Journal:  Infect Control Hosp Epidemiol       Date:  2015-03-10       Impact factor: 3.254

9.  Risk factors for development of intestinal colonization with imipenem-resistant Pseudomonas aeruginosa in the intensive care unit setting.

Authors:  Anthony D Harris; J Kristie Johnson; Kerri A Thom; Daniel J Morgan; Jessina C McGregor; Adebola O Ajao; Anita C Moore; Angela C Comer; Jon P Furuno
Journal:  Infect Control Hosp Epidemiol       Date:  2011-07       Impact factor: 3.254

10.  Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.

Authors:  Sandra Dial; Khalid Alrasadi; Chantal Manoukian; Allen Huang; Dick Menzies
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.